Conservation of Breast Cancer Molecular Subtypes and Transcriptional Patterns of Tumor Progression Across Distinct Ethnic Populations

Purpose: Breast cancers can display distinct clinical characteristics in different ethnic populations. Previous studies involving European and United States patients have shown that breast tumors can be divided by their gene expression profiles into distinct “molecular subtypes.” In this report, we surveyed a series of invasive and preinvasive breast tumors from Asian-Chinese patients to investigate whether similar subtypes could also be observed in this ethnic group. Experimental Design and Results: An analysis of expression profiles generated from 11 nonmalignant breast tissues, 17 ductal carcinomas in situ (DCIS) and 98 invasive carcinomas identified three broad molecular subtypes of breast [estrogen receptor (ER)+, ERBB2+ and ER−] in the Asian-Chinese population. These subtypes were highly similar to the “Luminal,” “ERBB2+,” and “Basal” molecular subtypes defined in previous studies, and the subtype-specific expression signatures were also observed in preinvasive DCIS tumors. By comparing the expression profiles of nonmalignant DCIS and invasive breast cancers for two subtypes (ER+ and ERBB2+), we identified several genes that were regulated in both a common and subtype-specific manner during the normal/DCIS and DCIS/invasive carcinoma transitions. Several of these genes were validated by comparison with another recently published similar, but not identical, study. Conclusions: Our results suggest that molecularly similar subtypes of breast cancer are indeed broadly conserved between Asian and Caucasian patients, and that these subtypes are already present at the preinvasive stage of carcinogenesis. To our knowledge, this study is among the first to directly compare the expression profiles of breast tumors across two different ethnic populations.

[1]  B. Henderson,et al.  Do urinary estrogen metabolites reflect the differences in breast cancer risk between Singapore Chinese and United States African-American and white women? , 2001, Cancer research.

[2]  R. Salunga,et al.  Gene expression profiles of human breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D M Barnes,et al.  Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance? , 1992, European journal of cancer.

[4]  Carsten O. Peterson,et al.  Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. , 2001, Cancer research.

[5]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Kikuno,et al.  Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. , 1993, The Biochemical journal.

[7]  E. Robecchi.  [Pathology of the breast]. , 1954, Minerva ginecologica.

[8]  P. Rosen,et al.  Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. , 1978 .

[9]  T. Golub,et al.  A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer , 2003, Cell.

[10]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Sudbø,et al.  Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.

[12]  E. Ostrander,et al.  BRCA1 and BRCA2 Mutations in Women from Shanghai China , 2004, Cancer Epidemiology Biomarkers & Prevention.

[13]  Philip M. Long,et al.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Mcphee,et al.  Current Medical Diagnosis and Treatment , 2009, Journal of Nuclear Medicine.

[15]  N. Day,et al.  Cancer incidence in Singapore 1968-1977. , 1984, IARC scientific publications.

[16]  L. Kruglyak,et al.  Genetic Dissection of Transcriptional Regulation in Budding Yeast , 2002, Science.

[17]  W. Dupont,et al.  Intraductal carcinoma of the breast: Follow‐up after biopsy only , 1982, Cancer.

[18]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  N. Wong,et al.  Genetic imbalances in pT2 breast cancers of southern Chinese women. , 2001, Cancer genetics and cytogenetics.

[20]  R. Stoughton,et al.  Genetics of gene expression surveyed in maize, mouse and man , 2003, Nature.

[21]  Kornelia Polyak,et al.  Molecular markers in ductal carcinoma in situ of the breast. , 2003, Molecular cancer research : MCR.

[22]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[23]  K. Kinzler,et al.  Genes expressed in human tumor endothelium. , 2000, Science.

[24]  C. Ford,et al.  Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  C. Muir,et al.  Cancer incidence in Singapore , 1967 .

[26]  P. Rosen,et al.  The clinical significance of pre‐invasive breast carcinoma , 1980, Cancer.

[27]  M. Polymeropoulos,et al.  Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer. , 2003, Cancer research.

[28]  Jing Yin,et al.  An Unsupervised Approach to Identify Molecular Phenotypic Components Influencing Breast Cancer Features , 2004, Cancer Research.

[29]  M. Ringnér,et al.  Gene expression in inherited breast cancer. , 2002, Advances in cancer research.

[30]  X. Shu,et al.  Insulin-like growth factors and breast cancer risk in Chinese women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[31]  J. Marks,et al.  A SAGE (serial analysis of gene expression) view of breast tumor progression. , 2001, Cancer research.

[32]  B. Haffty,et al.  A comparison of five immunohistochemical biomarkers and HER‐2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early‐onset breast carcinoma , 2003, Cancer.

[33]  R. W. Hughes.  Current medical diagnosis and treatment , 1978 .

[34]  H. Varmus,et al.  Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[36]  Russell D. Wolfinger,et al.  The contributions of sex, genotype and age to transcriptional variance in Drosophila melanogaster , 2001, Nature Genetics.

[37]  M J O'Hare,et al.  Linking gene expression patterns to therapeutic groups in breast cancer. , 2000, Cancer research.

[38]  Vladimir Vapnik,et al.  Statistical learning theory , 1998 .

[39]  Vladimir B Bajic,et al.  Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptor. , 2003, Human molecular genetics.

[40]  John K. Wiencke,et al.  Impact of race/ethnicity on molecular pathways in human cancer , 2004, Nature Reviews Cancer.